Insights

Regulatory Research PEI combines regulatory tasks with active biomedical research, creating opportunities to offer advanced study collaborations, regulatory consulting, and access to scientific expertise for vaccine and biomedicine development pipelines.

Global Partnerships The institute supports international bodies (WHO, EMA, European Commission) and engages in joint initiatives (CEPI project ECOWASRegECs). This presents avenues for multinational project partnerships, compliance services, and cross-border clinical trial support.

Clinical Trial Support As the authority responsible for clinical trial approvals and pharmacovigilance, PEI could benefit from strategic partnerships offering trial design advisory, safety monitoring analytics, and post-market surveillance solutions for new vaccines and biomedicines.

Safety & Compliance With official batch testing, inspections, and scientific advice roles, there is potential to offer quality assurance instrumentation, audit services, and regulatory intelligence tools to strengthen PEI’s evaluation and manufacturing oversight capabilities.

Public Health Impact PEI’s focus on safe, effective, high-quality biomedicines and its substantial government backing suggest opportunities to position health-tech solutions, data analytics platforms, and governance dashboards that enhance transparency and decision-making for national vaccine programs.

Similar companies to Paul-Ehrlich-Institut

Paul-Ehrlich-Institut Tech Stack

Paul-Ehrlich-Institut uses 8 technology products and services including SAP FICO, Microsoft Access, Microsoft Outlook, and more. Explore Paul-Ehrlich-Institut's tech stack below.

  • SAP FICO
    Accounting
  • Microsoft Access
    Database Management Software
  • Microsoft Outlook
    Email
  • RequireJS
    Javascript Frameworks
  • Microsoft
    Miscellaneous
  • HSTS
    Security
  • Piwik PRO Core
    Web Analytics
  • Apache HTTP Server
    Web Servers

Paul-Ehrlich-Institut's Email Address Formats

Paul-Ehrlich-Institut uses at least 1 format(s):
Paul-Ehrlich-Institut Email FormatsExamplePercentage
First.Last@pei.deJohn.Doe@pei.de
83%
Last.First@pei.deDoe.John@pei.de
7%
FLast@pei.deJDoe@pei.de
6%
First_Last@pei.deJohn_Doe@pei.de
4%

Frequently Asked Questions

What is Paul-Ehrlich-Institut's official website and social media links?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's official website is pei.de and has social profiles on LinkedIn.

How much revenue does Paul-Ehrlich-Institut generate?

Minus sign iconPlus sign icon
As of July 2026, Paul-Ehrlich-Institut's annual revenue is estimated to be $25M - $50M.

What is Paul-Ehrlich-Institut's NAICS code?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Paul-Ehrlich-Institut have currently?

Minus sign iconPlus sign icon
As of July 2026, Paul-Ehrlich-Institut has approximately 458 employees across 2 continents, including EuropeNorth America. Key team members include President: S. V.Head Of Media And Public Relations: C. L.Head Of Unit: Safety Of Veterinary Immunological Products: R. W.. Explore Paul-Ehrlich-Institut's employee directory with LeadIQ.

What industry does Paul-Ehrlich-Institut belong to?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut operates in the Research Services industry.

What technology does Paul-Ehrlich-Institut use?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's tech stack includes SAP FICOMicrosoft AccessMicrosoft OutlookRequireJSMicrosoftHSTSPiwik PRO CoreApache HTTP Server.

What is Paul-Ehrlich-Institut's email format?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's email format typically follows the pattern of First.Last@pei.de. Find more Paul-Ehrlich-Institut email formats with LeadIQ.
Paul-Ehrlich-Institut logo

Paul-Ehrlich-Institut

Research ServicesHesse, Germany201-500 Employees

The Paul-Ehrlich-Institut is Germany’s Federal Institute for Vaccines and Biomedicines, combining regulatory responsibilities with active biomedical research. Based near Frankfurt in Langen, it operates under the Federal Ministry of Health and conducts research on biomedicines for humans and veterinary immunological products while also granting authorisations when benefits outweigh risks. The institute oversees clinical trial approvals, pharmacovigilance, official batch testing, scientific advice, and inspections, supporting public health through rigorous evaluation and monitoring of medicinal products. In addition to its regulatory duties, it engages in independent experimental research that informs and underpins its regulatory activities, aiming to improve access to safe, effective, and high-quality biomedicines. The organization collaborates with international bodies and contributes expert guidance to entities such as the WHO, EMA, and the European Commission, reflecting its dual role in science and regulation. A recent collaboration highlighted its ongoing international engagement, exemplified by partnerships and joint projects with global health organizations. The institute employs staff across its research and regulatory functions, reflecting its broad scope and public health mandate. } ) } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }

Section iconCompany Overview

Website
pei.de
NAICS Code
5417 - Scientific Research and Development Services
Employees
201-500

Section iconFunding & Financials

  • $25M - $50M

    Paul-Ehrlich-Institut's revenue is estimated to be in the range of $25M - $50M

Section iconFunding & Financials

  • $25M - $50M

    Paul-Ehrlich-Institut's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.